NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90)
- Location
- Location not listed
- Category
- Biotechnology Research
- Website
- nurexone.com
- About
NurExone Biologic is developing a revolutionary biological exosome based technology drug platform to treat damage in the Central Nerve System.
The breakthrough exosome-based technology was proven in preclinical studies to have the potential to treat spinal cord injuries.
- Phone
- Available after you start a conversation
Listed Products in GetFertilizer
Products from NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90) · Combine products for better results
No products
Contact this organization through the marketplace for current availability.